Long-Term Investment |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2017 | |||
| Long-term Investment | |||
| LONG-TERM INVESTMENT |
The Company holds 8,563,254 shares of Wize Pharma Inc. (formally known as OphthaliX) as of December 31, 2017 which as of such date represents 8.2% percent of Wize Pharma Inc's outstanding shares. The shares are classified as financial asset as designated at fair value through profit or loss. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for investment property. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|